MRSA screening of 'no benefit'

Universal MRSA screening of patients on admission to hospital is of 'no benefit' according to a Swiss study.

The finding calls into question the efficacy of universal screening as a method of reducing rates of hospital-acquired MRSA, a method that has been proposed by the DoH.

The study, carried out between July 2004 and May 2006, included 21,754 surgical patients at a Swiss teaching hospital.

Despite better identification of MRSA carriers, there was no reduction in MRSA infection rates during the screening period, compared with a six-month period when only usual infection control measures were applied.

Professor Mark Enright from the Division of Epidemiology, Public Health and Primary Care at Imperial College, London said: ‘It's disappointing that they didn't see an outcome in terms of transmission.'

GPletters@haymarket.com

JAMA 2007; 299:1149-57

Comment below and tell us what you think


 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus